Stockscreener 앱 받기
16.74
1.53%
-0.26
전일 마감가:
$17.00
열려 있는:
$17.02
하루 거래량:
9.18M
Relative Volume:
0.84
시가총액:
$19.18B
수익:
$16.54B
순이익/손실:
$-1.64B
주가수익비율:
-11.54
EPS:
-1.45
순현금흐름:
$749.00M
1주 성능:
+3.02%
1개월 성능:
-23.28%
6개월 성능:
-7.67%
1년 성능:
+28.77%
1일 변동 폭
$16.61
$17.07
1주일 범위
$16.34
$17.62
52주 변동 폭
$12.51
$22.80
테바 ADR Stock (TEVA) Company Profile
명칭
Teva Pharmaceutical Industries Ltd Adr
전화
972 (3) 914-8213
주소
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
TEVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
테바 ADR Stock (TEVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-10 | 업그레이드 | Argus | Hold → Buy |
| 2024-03-08 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-12 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-01-23 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-11-27 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-06 | 업그레이드 | UBS | Sell → Neutral |
| 2023-05-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-18 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-01-19 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-11-04 | 다운그레이드 | UBS | Neutral → Sell |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-08-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-06-14 | 재개 | UBS | Neutral |
| 2022-05-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-05-04 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2022-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-03-25 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-01-27 | 다운그레이드 | Argus | Buy → Hold |
| 2021-10-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-05-04 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-25 | 개시 | Oppenheimer | Perform |
| 2020-08-06 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2020-07-27 | 재개 | Goldman | Neutral |
| 2020-06-01 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-04-24 | 재개 | Citigroup | Neutral |
| 2020-04-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-02-24 | 다운그레이드 | Edward Jones | Hold → Sell |
| 2019-11-12 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-10-17 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2019-08-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-07-19 | 개시 | Wolfe Research | Peer Perform |
| 2019-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2019-07-10 | 재개 | Credit Suisse | Neutral |
| 2019-07-05 | 업그레이드 | Argus | Hold → Buy |
| 2019-06-11 | 개시 | Barclays | Underweight |
| 2019-06-03 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2019-05-30 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-05-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-07 | 재개 | UBS | Buy |
모두보기
테바 ADR 주식(TEVA)의 최신 뉴스
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease - GlobeNewswire Inc.
Validea Detailed Fundamental AnalysisTEVA - Nasdaq
Teva- Pharmaceutical Industries Ltd. ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
FHN’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle
Has Hesai Group Sponsored ADR (HSAI) Outpaced Other Auto-Tires-Trucks Stocks This Year? - Yahoo Finance
Recent Insider Activity Could Benefit Dover Corp (DOV) - Knox Daily
Analyzing Northern Trust Corp (NTRS) After Recent Trading Activity - Knox Daily
Understanding the Risks of Investing in QuinStreet Inc (QNST) - Knox Daily
why Teva- Pharmaceutical Industries Ltd. ADR [TEVA] is a Good Choice for Investors After New Price Target of $24.71 - The DBT News
fuboTV Inc [FUBO] is 213.49% higher this YTD. Is it still time to buy? - The DBT News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s stock price in review: A technical analysis - US Post News
Tilray Brands Inc (TLRY)’s stock price range in the last year - US Post News
AGNC Investment Corp (AGNC) stock analysis: A simple moving average approach - US Post News
What is the investor’s view on Nebius Group N.V (NBIS)? - US Post News
U.S. Bancorp (USB) Stock: A Closer Look at the Market Potential - The News Heater
Evaluating the Impact of 0.95 Increase on NIO Inc ADR’s (NIO) Stock - The News Heater
Comerica, Inc [CMA] Officer makes an insider purchase of 1,630 shares worth 0.11 million. - Knox Daily
Selling Buzz: Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Director MIGNONE ROBERTO sells 286,000 shares of the company – Knox Daily - Knox Daily
Vice President Thomson Andrew Justin Mackenzi sale 4,047 shares of T. Rowe Price Group Inc [TROW] - Knox Daily
SoundHound AI Inc [SOUN] stock for 409,436 USD was sold by MARCUS LAWRENCE - Knox Daily
Investors in cash trouble should check out Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - SETE News
Selling Buzz: Interpublic Group Of Cos., Inc [IPG] SVP, Controller & CAO CARROLL CHRISTOPHER F sells 18,382 shares of the company – Knox Daily - Knox Daily
United Community Banks Inc [UCB] Records 200-Day SMA of $29.14 - Knox Daily
There is no way Arrowhead Pharmaceuticals Inc (ARWR) can keep these numbers up - SETE News
A better buy-in window may exist right now for Sotera Health Co (SHC) - SETE News
Wall Street analysts’ outlook for Hamilton Lane Inc (HLNE) - SETE News
Insider Selling: MOSLEY WILLIAM D, Seagate Technology Holdings Plc [STX] Chief Executive Officer divested 20,000 shares – Knox Daily - Knox Daily
Confluent Inc [CFLT] stock for 113,437 USD was sold by Phan Kong - Knox Daily
A company insider recently sold 16,932 shares of Kroger Co [KR]. Should You Sale? - Knox Daily
3 Generic Drug Stocks to Watch - Morningstar
SaverOne Expands Driver Safety System Deployment with Teva Pharmaceutical - TipRanks
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Keeping an Eye on Omnicom Group, Inc (OMC) After Insider Trading Activity - Knox Daily
Understanding the Risks of Investing in Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - Knox Daily
TEVA Stock Quote Price and Forecast - CNN
Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO. - Investor's Business Daily
Are You Looking for a Top Momentum Pick? Why Sea Limited Sponsored ADR (SE) is a Great Choice - Yahoo Finance
Does Starbucks Corp (NASDAQ: SBUX) Still Need To Convince Analysts? - Stocks Register
Wells Fargo & Co (NYSE: WFC) Jumps 0.80%, Turning Investors Away - Stocks Register
Does Petroleo Brasileiro S.A. Petrobras ADR (NYSE: PBR) Still Look Hot This Week? - Stocks Register
MINISO Group Holding Limited Unsponsored ADR (MNSO) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Exicure Inc (XCUR) requires closer examination - US Post News
Citizens Financial Group Inc (NYSE: CFG) Stock Forecast: Bearish Sentiment Points To -1.52% Downside In 2025 - Stocks Register
Is It Worth Investing in PDD Holdings Inc. Sponsored ADR (PDD) Based on Wall Street's Bullish Views? - Yahoo Finance
Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Hewlett Packard Enterprise Co (NYSE: HPE) Stock Forecast: Could Pass $29 In A Year - Stocks Register
Citigroup Inc (NYSE: C) Up 37.25% This Year: What Is Going To Happen Next - Stocks Register
Where Do Analysts Think The Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Is Going - Stocks Register
Is Capricorn Energy PLC Unsponsored ADR (CRNCY) Stock Outpacing Its Oils-Energy Peers This Year? - Yahoo Finance
New Strong Buy Stocks for January 2nd - Yahoo Finance
Are Medical Stocks Lagging Brainsway (BWAY) This Year? - Yahoo Finance
테바 ADR (TEVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
0.51%
자본화:
|
볼륨(24시간):